VanEck's concentrated 25-stock biotech portfolio surged 40.5% in one year, but Fidelity's diversified 365-holding fund delivered superior risk-adjusted returns with half the volatility.
VanEck Biotech ETF (BBH) News
Latest headlines that mention BBH, newest first · each headline opens the original publisher
- Last price
- $250.46
- Day change
- +0.68%
- Next earnings
- —
BBH headlines
latest coverageNot much coverage yet. BBH has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Also mentioned with BBH
30dHeadlines that tag both tickers
BBH news alerts
Get an alert by email or push when a new headline mentions BBH.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.